DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to ...
February 5, 2010 (Washington, DC) — Transvenous extraction of implanted-device leads using a laser catheter is nearly always completed successfully and poses little risk of death or other major ...
Spectranetics of Colorado Springs and Denver-based Medical Simulation Corp. announced a new, advanced laser lead-extraction simulation system to augment training for physicians and help them gain ...
October 11, 2011 (Miami, Florida) — Percutaneous removal of pacemaker and implantable cardioverter defibrillator (ICD) leads using a laser catheter can be achieved as effectively and safely in ...
COLORADO SPRINGS, Colo., Dec. 8, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (NASDAQ:SPNC) today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission ...
Laser lead extraction is a safe and effective treatment method in octogenarian patients with multiple comorbidities, new data suggest. For a recent study, patients who underwent laser lead extraction ...
This study on the Pacemaker/Defibrillator Lead Extraction Kits Market is a data-driven insight into its key evolution trajectories and scrutiny of the current and emerging avenues in the various ...
Spectranetics Corp., the Colorado Springs-based medical laser manufacturer, said Tuesday it has agreed to pay nearly $8.9 million to settle a pair of legal actions brought by stockholders against the ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC - News) today announced that the Ministry of Health, Labor and Welfare in Japan has approved product reimbursement to ...
COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback